Rapport Therapeutics COO Cheryl Gault sells USD 332,992 of common stock

• Rapport Therapeutics COO Cheryl Gault sold 10,000 common shares on Sept. 30, 2026.
• Sales priced at USD 33.0364 per share for 7,925 shares; USD 33.7556 per share for 2,075 shares.
• Holdings fell to 139,914 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-410734), on October 01, 2026, and is solely responsible for the information contained therein.